#Exome
Integrative Analysis of Whole-Exome Sequencing and Machine Learning Reveals Rare Genetic Signatures Associated with Chronic Insomnia Disorder https://doi.org/10.3390/ijms272210211 #Polymorphism
November 16, 2026 at 11:06 AM
📢 A recent systematic review form our latest issue assesses the health economic evidence for the use of WES & WGS and finds that these technologies can be cost-effective depending on the clinical and geographical context. 🧬
@jbuchanan-ox.bsky.social

🔗 Read more: www.nature.com/articles/s41...
The cost and cost-effectiveness of whole-exome and whole-genome sequencing: a systematic literature review - European Journal of Human Genetics
European Journal of Human Genetics - The cost and cost-effectiveness of whole-exome and whole-genome sequencing: a systematic literature review
www.nature.com
November 18, 2026 at 10:57 AM
Whole-exome sequencing of 4 siblings (3 with TKA; 2 with recurrent PJI) identified 22 candidate genes; database review highlighted JAGN1 and SERPINA10 as plausible PJI susceptibility genes.
Genetic Susceptibility to Periprosthetic Joint Infection in Total Knee Arthroplasty: Insights From Familial Analysis
AbstractThe susceptibility to periprosthetic joint infection (PJI) likely has a genetic component. However, the responsible genes are unknown. We performed whole-exome sequencing on 4 siblings, 3 of whom had undergone total knee arthroplasty (TKA), of whom 2 suffered from recurrent PJI. Evaluation of rare genetic variants found in the affected siblings (TKA with PJI) yielded a list of 22 candidate genes. Searching each of these in the NCBI database yielded 2 with a plausible role in susceptibility to PJI: JAGN1 and SERPINA10.
academic.oup.com
November 17, 2026 at 6:00 PM
The genetic landscape of canine tumors: Insights from the Canine Cancer Genome Atlas (CCGA) | Science www.science.org/doi/10.1126/...
The genetic landscape of canine tumors: Insights from the Canine Cancer Genome Atlas (CCGA)
The Canine Cancer Genome Atlas (CCGA, https://caninecancergenomeatlas.org/) is an open, accessible comparative oncology resource that harmonizes whole-exome data across 10 canine tumor histotypes. It ...
www.science.org
November 14, 2026 at 3:46 PM
Invasive Lobular Carcinoma With Extracellular Mucin Production: First Whole Exome Sequencing of a Rare Histological Variant of Breast Carcinoma

@modernpathology.bsky.social

Read More: buff.ly/C60TUCs
November 13, 2026 at 7:03 PM
S5719
A bill to amend title XIX of the Social Security Act to clarify that whole genome and whole exome sequencing for children with certain medical need...

📢 Introduced in Senate

https://congress.gov/bill/119th-congress/senate-bill/5719

#S5719 #congress119 #senate #republican #congress #newbill
November 17, 2026 at 12:13 PM
Integrated exome-transcriptome analysis of a schizophrenia case with an exceptionally low polygenic risk score https://www.biorxiv.org/content/10.64898/2026.11.09.765277v1
November 11, 2026 at 1:33 PM
Integrated exome-transcriptome analysis of a schizophrenia case with an exceptionally low polygenic risk score https://www.biorxiv.org/content/10.64898/2026.11.09.765277v1
November 11, 2026 at 1:33 PM
Comprehensive Characterization of Somatic Mutations and Gene Expression on TP53/PTEN DKO Murine Glioblastoma Cell Lines: Insights from Whole-Exome and RNA-seq Analysis https://www.biorxiv.org/content/10.64898/2026.11.10.765700v1
November 11, 2026 at 10:45 PM
Comprehensive Characterization of Somatic Mutations and Gene Expression on TP53/PTEN DKO Murine Glioblastoma Cell Lines: Insights from Whole-Exome and RNA-seq Analysis https://www.biorxiv.org/content/10.64898/2026.11.10.765700v1
November 11, 2026 at 10:45 PM
The genetic landscape of canine tumors: Insights from the Canine Cancer Genome Atlas (CCGA) | Science
The genetic landscape of canine tumors: Insights from the Canine Cancer Genome Atlas (CCGA) | Science
The Canine Cancer Genome Atlas (CCGA, https://caninecancergenomeatlas.org/) is an open, accessible comparative oncology resource that harmonizes whole-exome data across 10 canine tumor histotypes. It aggregates 667 tumor-normal pairs with curated single-...
www.science.org
November 12, 2026 at 8:15 PM
De novo mutations hide in genome’s messiest spots, like homopolymers and tandem repeats. 🧬 In recent benchmarks, ABC™ showed an order-of-magnitude lower homopolymer error rate than other platforms. 🎯

New blog: exome vs. genome vs. trio sequencing for rare disease research.

https://bit.ly/4AMt6rF
November 11, 2026 at 5:18 PM
Exome sequencing of six men with asthenozoospermia identified six DNAH14 variants. In Dnah14-disrupted mice, sperm flagella beat at higher frequency but with reduced amplitude. Males were subfertile, and their sperm showed abnormal mitochondria with reduced oxidative phosphorylation and glycolysis.
November 10, 2026 at 11:00 PM
Invasive Lobular Carcinoma With Extracellular Mucin Production: First Whole Exome Sequencing of a Rare Histological Variant of Breast Carcinoma

@modernpathology.bsky.social

Read More: buff.ly/GyHpWGl
November 7, 2026 at 7:02 PM
Prospective and genetic analyses implicate lower immunosurveillance in the aetiology of prostate cancer
A graphical summary of the study design is presented in Fig. 1, encompassing prospective observational analyses in EPIC and UK Biobank, meta-analyses of observational results, genetic evidence from Mendelian randomisation and exome-wide score analyses, and integrated and cross-cancer analyses. Observational analyses In EPIC, median age at PC diagnosis was 67 years [Interquartile range (IQR): 63–72], and the median time from blood collection to PC diagnosis was 12.2 years [IQR: 4.5-14.5]. Small differences were observed in body mass index (BMI) and smoking status between men who were diagnosed with PC and their matched controls. No other differences were observed in participant characteristics by case status (Table 1). In the UKBB study, the median age at PC diagnosis was 69 years [IQR: 65–73]. For men who developed PC, the median duration from blood collection to diagnosis was 6.6 years [IQR: 3.6–9.2]. Differences in various factors were observed between men who were and were not diagnosed with PC during follow-up, including in BMI, Townsend deprivation index, smoking status, and family history of PC (Supplementary Information-Table S2). Overall prostate cancer Figure 2 presents volcano plots of the associations of all 368 proteins with overall prostate cancer risk in the EPIC and UK Biobank cohorts...
www.nature.com
November 11, 2026 at 3:24 AM
Systematic review & meta-analysis of 46 studies found exome/genome sequencing (ES/GS) each diagnosed ~39% of critically ill patients w/suspected genetic disorders. GS showed trends toward higher yield, supporting early genomic testing in NICU/PICU care bit.ly/4fjl6FW
November 9, 2026 at 6:10 PM
Clinical Whole Exome Sequencing WES Market Growth Trends 2035 | WiseGuyReports www.wiseguyreports.com/reports/clin...
Clinical Whole Exome Sequencing WES Market Growth Trends 2035
Clinical Whole Exome Sequencing WES Market is likely to Reach From USD 2400 Billion To USD 5 Billion by 2035, Growing at a CAGR of 7.8% During 2026 - 2035
www.wiseguyreports.com
November 6, 2026 at 7:01 AM
Exome. I know this word. My fingers don't always know.
November 5, 2026 at 5:47 AM
While the findings pave the way for identifying potential clinical therapeutic targets, the study note that functional validation and replication in independent, diverse cohorts are still required to fully translate these discover

pmc.ncbi.nlm.nih.gov/articles/PMC...
Deciphering Host Genomic Pathway Landscapes in Severe COVID‐19 by Exome Sequencing of a Large Admixed Brazilian Cohort
The host genetic factors that resulted in the heterogeneous clinical outcomes of COVID‐19 remained poorly understood, especially in admixed populations that are underrepresented in global genomic stud...
pmc.ncbi.nlm.nih.gov
November 7, 2026 at 1:18 AM